APA (7th ed.) Citation

GA, B., AJ, B., AL, S., DE, W., RI, L., Y, Y., . . . GM, C. (2026). Correction to: Safety and Efficacy of Tenapanor for Long-term Serum Phosphate Control in Maintenance Dialysis: A 52-Week Randomized Phase 3 Trial (PHREEDOM). Kidney360, 7(6), 1434. https://doi.org/10.34067/KID.0000001245

Chicago Style (17th ed.) Citation

GA, Block, Bleyer AJ, Silva AL, Weiner DE, Lynn RI, Yang Y, Rosenbaum DP, and Chertow GM. "Correction to: Safety and Efficacy of Tenapanor for Long-term Serum Phosphate Control in Maintenance Dialysis: A 52-Week Randomized Phase 3 Trial (PHREEDOM)." Kidney360 7, no. 6 (2026): 1434. https://doi.org/10.34067/KID.0000001245.

MLA (9th ed.) Citation

GA, Block, et al. "Correction to: Safety and Efficacy of Tenapanor for Long-term Serum Phosphate Control in Maintenance Dialysis: A 52-Week Randomized Phase 3 Trial (PHREEDOM)." Kidney360, vol. 7, no. 6, 2026, p. 1434, https://doi.org/10.34067/KID.0000001245.